The analysis also found high levels of community deaths in some countries, which highlights serious gaps in treatment.
A shortage of oral cholera vaccine still complicates response efforts, with demand nearly double the number of doses produced since 2023.
Compared to last year, cholera cases are down 32%, but deaths are up 14%.
Two facilities in South Korea are expected to begin producing the vaccine in the second quarter of the year, which is expected to help ease severe vaccine shortages.
Kids are the most affected group in the DRC's mpox outbreak, and their exposure is coming from household contacts and small animals.
The doctor who contracted the severe fever with thrombocytopenia syndrome virus had no history of recent tick bites and didn't have pets.
In cholera developments, Comoros last month reported its first outbreak since 2008.
Sixteen countries are struggling to contain outbreaks of the deadly illness, and the ability to make more vaccine is limited to its sole manufacturer.
Oral cholera vaccine shortages are still critical, with the global stockpile depleted.
GSK has applied for expanded RSV vaccine use in adults ages 50 to 59 who have underlying health conditions.
